Global Interventional Cardiovascular Device Market Growth 2025-2031

Publication ID:

LPI01254828

Publication Date:

January 14, 2025

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Interventional Cardiovascular Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淚nterventional Cardiovascular Device Industry Forecast鈥� looks at past sales and reviews total world Interventional Cardiovascular Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Interventional Cardiovascular Device sales for 2025 through 2031. With Interventional Cardiovascular Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Cardiovascular Device industry.
This Insight Report provides a comprehensive analysis of the global Interventional Cardiovascular Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Cardiovascular Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Interventional Cardiovascular Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Cardiovascular Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Cardiovascular Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Cardiovascular Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Imaging System
Catheter
PTCA Balloon
Stent
PTCA Guidewire
Other
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Boston Scientific
Philips
Volcano Therapeutics
Argon Medical
Spectranetics
Angio Dynamics
AccessClosure
Merit Medical Systems
B. Braun
C. R. Bard
Marine Polymer Technologies
Cordis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Interventional Cardiovascular Device market?
What factors are driving Interventional Cardiovascular Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interventional Cardiovascular Device market opportunities vary by end market size?
How does Interventional Cardiovascular Device break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Cardiovascular Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Interventional Cardiovascular Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Interventional Cardiovascular Device by Country/Region, 2020, 2024 & 2031
2.2 Interventional Cardiovascular Device Segment by Type
2.2.1 Imaging System
2.2.2 Catheter
2.2.3 PTCA Balloon
2.2.4 Stent
2.2.5 PTCA Guidewire
2.2.6 Other
2.3 Interventional Cardiovascular Device Sales by Type
2.3.1 Global Interventional Cardiovascular Device Sales Market Share by Type (2020-2025)
2.3.2 Global Interventional Cardiovascular Device Revenue and Market Share by Type (2020-2025)
2.3.3 Global Interventional Cardiovascular Device Sale Price by Type (2020-2025)
2.4 Interventional Cardiovascular Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Interventional Cardiovascular Device Sales by Application
2.5.1 Global Interventional Cardiovascular Device Sale Market Share by Application (2020-2025)
2.5.2 Global Interventional Cardiovascular Device Revenue and Market Share by Application (2020-2025)
2.5.3 Global Interventional Cardiovascular Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Interventional Cardiovascular Device Breakdown Data by Company
3.1.1 Global Interventional Cardiovascular Device Annual Sales by Company (2020-2025)
3.1.2 Global Interventional Cardiovascular Device Sales Market Share by Company (2020-2025)
3.2 Global Interventional Cardiovascular Device Annual Revenue by Company (2020-2025)
3.2.1 Global Interventional Cardiovascular Device Revenue by Company (2020-2025)
3.2.2 Global Interventional Cardiovascular Device Revenue Market Share by Company (2020-2025)
3.3 Global Interventional Cardiovascular Device Sale Price by Company
3.4 Key Manufacturers Interventional Cardiovascular Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interventional Cardiovascular Device Product Location Distribution
3.4.2 Players Interventional Cardiovascular Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Interventional Cardiovascular Device by Geographic Region
4.1 World Historic Interventional Cardiovascular Device Market Size by Geographic Region (2020-2025)
4.1.1 Global Interventional Cardiovascular Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Interventional Cardiovascular Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Interventional Cardiovascular Device Market Size by Country/Region (2020-2025)
4.2.1 Global Interventional Cardiovascular Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Interventional Cardiovascular Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Interventional Cardiovascular Device Sales Growth
4.4 APAC Interventional Cardiovascular Device Sales Growth
4.5 Europe Interventional Cardiovascular Device Sales Growth
4.6 Middle East & Africa Interventional Cardiovascular Device Sales Growth
5 Americas
5.1 Americas Interventional Cardiovascular Device Sales by Country
5.1.1 Americas Interventional Cardiovascular Device Sales by Country (2020-2025)
5.1.2 Americas Interventional Cardiovascular Device Revenue by Country (2020-2025)
5.2 Americas Interventional Cardiovascular Device Sales by Type (2020-2025)
5.3 Americas Interventional Cardiovascular Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Cardiovascular Device Sales by Region
6.1.1 APAC Interventional Cardiovascular Device Sales by Region (2020-2025)
6.1.2 APAC Interventional Cardiovascular Device Revenue by Region (2020-2025)
6.2 APAC Interventional Cardiovascular Device Sales by Type (2020-2025)
6.3 APAC Interventional Cardiovascular Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Interventional Cardiovascular Device by Country
7.1.1 Europe Interventional Cardiovascular Device Sales by Country (2020-2025)
7.1.2 Europe Interventional Cardiovascular Device Revenue by Country (2020-2025)
7.2 Europe Interventional Cardiovascular Device Sales by Type (2020-2025)
7.3 Europe Interventional Cardiovascular Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interventional Cardiovascular Device by Country
8.1.1 Middle East & Africa Interventional Cardiovascular Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Interventional Cardiovascular Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Interventional Cardiovascular Device Sales by Type (2020-2025)
8.3 Middle East & Africa Interventional Cardiovascular Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interventional Cardiovascular Device
10.3 Manufacturing Process Analysis of Interventional Cardiovascular Device
10.4 Industry Chain Structure of Interventional Cardiovascular Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interventional Cardiovascular Device Distributors
11.3 Interventional Cardiovascular Device Customer
12 World Forecast Review for Interventional Cardiovascular Device by Geographic Region
12.1 Global Interventional Cardiovascular Device Market Size Forecast by Region
12.1.1 Global Interventional Cardiovascular Device Forecast by Region (2026-2031)
12.1.2 Global Interventional Cardiovascular Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Interventional Cardiovascular Device Forecast by Type (2026-2031)
12.7 Global Interventional Cardiovascular Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Interventional Cardiovascular Device Product Portfolios and Specifications
13.1.3 GE Healthcare Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Interventional Cardiovascular Device Product Portfolios and Specifications
13.2.3 Boston Scientific Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Philips
13.3.1 Philips Company Information
13.3.2 Philips Interventional Cardiovascular Device Product Portfolios and Specifications
13.3.3 Philips Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Philips Main Business Overview
13.3.5 Philips Latest Developments
13.4 Volcano Therapeutics
13.4.1 Volcano Therapeutics Company Information
13.4.2 Volcano Therapeutics Interventional Cardiovascular Device Product Portfolios and Specifications
13.4.3 Volcano Therapeutics Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Volcano Therapeutics Main Business Overview
13.4.5 Volcano Therapeutics Latest Developments
13.5 Argon Medical
13.5.1 Argon Medical Company Information
13.5.2 Argon Medical Interventional Cardiovascular Device Product Portfolios and Specifications
13.5.3 Argon Medical Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Argon Medical Main Business Overview
13.5.5 Argon Medical Latest Developments
13.6 Spectranetics
13.6.1 Spectranetics Company Information
13.6.2 Spectranetics Interventional Cardiovascular Device Product Portfolios and Specifications
13.6.3 Spectranetics Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Spectranetics Main Business Overview
13.6.5 Spectranetics Latest Developments
13.7 Angio Dynamics
13.7.1 Angio Dynamics Company Information
13.7.2 Angio Dynamics Interventional Cardiovascular Device Product Portfolios and Specifications
13.7.3 Angio Dynamics Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Angio Dynamics Main Business Overview
13.7.5 Angio Dynamics Latest Developments
13.8 AccessClosure
13.8.1 AccessClosure Company Information
13.8.2 AccessClosure Interventional Cardiovascular Device Product Portfolios and Specifications
13.8.3 AccessClosure Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 AccessClosure Main Business Overview
13.8.5 AccessClosure Latest Developments
13.9 Merit Medical Systems
13.9.1 Merit Medical Systems Company Information
13.9.2 Merit Medical Systems Interventional Cardiovascular Device Product Portfolios and Specifications
13.9.3 Merit Medical Systems Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Merit Medical Systems Main Business Overview
13.9.5 Merit Medical Systems Latest Developments
13.10 B. Braun
13.10.1 B. Braun Company Information
13.10.2 B. Braun Interventional Cardiovascular Device Product Portfolios and Specifications
13.10.3 B. Braun Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 B. Braun Main Business Overview
13.10.5 B. Braun Latest Developments
13.11 C. R. Bard
13.11.1 C. R. Bard Company Information
13.11.2 C. R. Bard Interventional Cardiovascular Device Product Portfolios and Specifications
13.11.3 C. R. Bard Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 C. R. Bard Main Business Overview
13.11.5 C. R. Bard Latest Developments
13.12 Marine Polymer Technologies
13.12.1 Marine Polymer Technologies Company Information
13.12.2 Marine Polymer Technologies Interventional Cardiovascular Device Product Portfolios and Specifications
13.12.3 Marine Polymer Technologies Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Marine Polymer Technologies Main Business Overview
13.12.5 Marine Polymer Technologies Latest Developments
13.13 Cordis
13.13.1 Cordis Company Information
13.13.2 Cordis Interventional Cardiovascular Device Product Portfolios and Specifications
13.13.3 Cordis Interventional Cardiovascular Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Cordis Main Business Overview
13.13.5 Cordis Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂